Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Effect of pharmacist email alerts on concurrent prescribing of opioids and benzodiazepines by prescribers and primary care managers: a randomized clinical trial.

Sacarny A, Safran E, Steffel M, et al. Effect of pharmacist email alerts on concurrent prescribing of opioids and benzodiazepines by prescribers and primary care managers: a randomized clinical trial. JAMA Health Forum. 2022;3(9):e223378. 10.1001/jamahealthforum.2022.3378

Save
Print
October 26, 2022
Sacarny A, Safran E, Steffel M, et al. JAMA Health Forum. 2022;3(9):e223378.
View more articles from the same authors.

Concurrent prescribing of opioids and benzodiazepines can put patients at increased risk of overdose. This randomized study found that pharmacist email alerts to clinicians caring for patients recently co-prescribed opioids and benzodiazepines did not reduce concurrent prescribing of these medications.

Save
Print
Cite
Citation

Sacarny A, Safran E, Steffel M, et al. Effect of pharmacist email alerts on concurrent prescribing of opioids and benzodiazepines by prescribers and primary care managers: a randomized clinical trial. JAMA Health Forum. 2022;3(9):e223378. 10.1001/jamahealthforum.2022.3378

Related Resources From the Same Author(s)
Related Resources